QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment

Women have higher risk for developing TdP in response to ventricular repolarization prolonging drugs. Hundreds of trials are administering chloroquine and hydroxychloroquine with/without azithromycin to COVID-19 patients. While an overall prolonged QTc has been reported in COVID-19 patients undergoi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sarah Grewal, Lior Jankelson, Marcel P. H. van den Broek, Martin Cour, Gloria Bachmann, John B. Kostis, Kamana Misra
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2020-09-01
Colección:	Frontiers in Cardiovascular Medicine
Materias:	COVID QTc changes hydroxychloroquine chloroquin azithromycin (AZM) QTc
Acceso en línea:	https://www.frontiersin.org/article/10.3389/fcvm.2020.00152/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!